The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AVEO Pharmaceuticals, Inc(NASDAQ:AVEO) 
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of ren...
Website: http://www.aveooncology.com
Founded: 2001
Full Time Employees: 49 (May 2021)
Sector: Healthcare
Industry: Biotechnology
AVEO Pharmaceuticals Days Payable Outstanding ttm (DPO)
AVEO Pharmaceuticals Days Receivable Outstanding ttm (DSO)
AVEO Pharmaceuticals Days Inventory Outstanding ttm (DIO)
AVEO Pharmaceuticals Op Cashflow Per Share ttm
AVEO Pharmaceuticals Free Cashflow Per Share ttm
AVEO Pharmaceuticals Cash Per Share ttm
AVEO Pharmaceuticals P/S ratio ttm
AVEO Pharmaceuticals (GAAP) P/E ratio ttm
AVEO Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.